Alterations in sociability and functional brain connectivity caused by early-life seizures are prevented by

Gregory L Holmes1, Chengju Tian1, Amanda E Hernan1

  • 1Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT05405, USA.

Insights

Early-life seizures in rats disrupt brain connectivity and lead to autism-like behaviors. Treating with bumetanide during seizures prevented these deficits, suggesting a potential therapeutic target for early-life epilepsy and autism spectrum disorder.

Area of Science:

  • Neuroscience
  • Developmental Neuroscience
  • Autism Spectrum Disorder Research

Background:

  • Infantile epilepsy is linked to cognitive and behavioral issues, including autism spectrum disorders (ASD).
  • The exact mechanisms connecting early-life seizures to ASD development remain unclear.
  • Autism is increasingly viewed as a disorder of brain connectivity.

Purpose of the Study:

  • To investigate if early-life seizures disrupt brain connectivity during maturation, leading to an autistic phenotype.
  • To examine how early-life seizures alter brain oscillatory activity and inter-regional communication.
  • To assess the impact of early-life seizures on social behavior and seizure susceptibility.

Main Methods:

  • Recurrent flurothyl-induced seizures were administered to rat pups from postnatal days 5-14.
  • Brain oscillatory activity was recorded from the hippocampus and prefrontal cortex (Pdays 18-25).
  • Sociability, social novelty, open field tests, and seizure thresholds were assessed. Bumetanide was administered during the seizure period in a subset of rats.

Main Results:

  • Early-life seizures increased coherence and decreased voltage correlation between brain regions, without significantly altering total or relative power spectral densities.
  • Seizure-exposed rats showed impaired sociability and social novelty but no increased anxiety or activity.
  • Rats with early-life seizures had lower seizure thresholds, indicating altered excitatory/inhibitory balance. Bumetanide treatment prevented these abnormalities.

Conclusions:

  • Early-life seizures disrupt the development of brain oscillations and connectivity, resulting in autistic-like behaviors.
  • Altered communication between brain regions following early seizures may underlie social cognitive deficits in ASD.
  • Targeting NKCC1 with bumetanide during early-life seizures can prevent the development of autistic-like behaviors and normalize seizure threshold.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.4K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
122
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K